The peripheral profile of the chitinase 3-like-1 in benign multiple sclerosis - a single centre's experience

CONCLUSIONS: Our findings suggest that there are no differences in serum CHI3L1 levels between BMS patients and HC. However, serum CHI3L1 levels are sensitive to clinical inflammatory activity and may be associated with relapses in BMS patients.PMID:37303176 | DOI:10.2174/1871527322666230609164534
Source: CNS and Neurological Disorders Drug Targets - Category: Drugs & Pharmacology Authors: Source Type: research